Abstract
Objective
Observational studies suggested that peripheral blood eosinophils were associated with the risk of nasal polyps. However, these studies did not confirm the causality. This study aims to apply Mendelian randomization (MR) method to comprehensively assess the potential causal association between peripheral blood eosinophils and nasal polyps.
Methods
Genetic instrumental variables were extracted from the largest available genome-wide association study (GWAS) of European participants, which were used to investigate the relationship between peripheral blood eosinophils and nasal polyps. The inverse variance weighted method, the MR Egger method, and the weighted median method were applied for this analysis. MR-Egger intercept tests, leave-one-out analyses, and funnel plots were performed for the sensitivity analysis.
Results
With the inverse variance weighted method, the MR analysis suggested that there was a significant difference between peripheral blood eosinophils and the risk of nasal polyps (ukb-a-97, OR 1.004, 95% CI 1.003–1.005, p < 0.001; ukb-a-541, OR 1.005, 95% CI 1.004–1.006, p < 0.001; ukb-b-7211, OR 1.004, 95% CI 1.003–1.005, p < 0.001; ukb-b-8425, OR 1.004, 95% CI 1.003–1.005, p < 0.001; finn-b-J10_NASALPOLYP, OR 3.089, 95% CI 2.537–3.761, p < 0.001). Consistent results were also proved by using the weighted median method and the MR Egger method.
Conclusions
Our findings reveal the causal effect of peripheral blood eosinophils on the increased risk of nasal polyps.
Data availability
Not applicable.
References
Hopkins C (2019) Chronic rhinosinusitis with nasal polyps. N Engl J Med 381:55–63
Bachert C, Han JK, Desrosiers M et al (2019) Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet 394:1638–1650
Agache I, Song Y, Alonso-Coello P et al (2021) Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: a systematic review for the EAACI guidelines. Allergy 76:2337–2353
Pongdee T, Bielinski SJ, Decker PA, Kita H, Larson NB (2022) White blood cells and chronic rhinosinusitis: a Mendelian randomization study. Allergy Asthma Clin Immunol 18:98
Luo Q, Zhou S, Yuan B et al (2023) Blood eosinophil count in the diagnosis of allergic-like rhinitis with chronic rhinosinusitis. Clin Otolaryngol 48:339–346
Delemarre T, Holtappels G, De Ruyck N et al (2020) Type 2 inflammation in chronic rhinosinusitis without nasal polyps: Another relevant endotype. J Allergy Clin Immunol 146:337–343
Wang Z, Wang Q, Duan S et al (2022) A diagnostic model for predicting type 2 nasal polyps using biomarkers in nasal secretion. Front Immunol 13:1054201
Gevaert P, Lang-Loidolt D, Lackner A et al (2006) Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps. J Allergy Clin Immunol 118:1133–1141
Davies NM, Holmes MV, Davey SG (2018) Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ 362:k601
Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey SG (2008) Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 27:1133–1163
Richmond RC, Davey SG (2022) Mendelian randomization: concepts and scope. Cold Spring Harb Perspect Med 12:a040501
Skrivankova VW, Richmond RC, Woolf B et al (2021) Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement. JAMA 326:1614–1621
Zhang Z, Li G, Yu L et al (2022) Causal relationships between potential risk factors and chronic rhinosinusitis: a bidirectional two-sample Mendelian randomization study. Eur Arch Otorhinolaryngol 280:2785–2793
Park S, Lee S, Kim Y et al (2021) Atrial fibrillation and kidney function: a bidirectional Mendelian randomization study. Eur Heart J 42:2816–2823
Wei Y, Zhan Y, Carlsson S (2023) Childhood adiposity and novel subtypes of diabetes in adults: a Mendelian randomisation and genome-wide genetic correlation study. Lancet Glob Health 11(Suppl 1):S1
Emdin CA, Khera AV, Kathiresan S (2017) Mendelian randomization. JAMA 318:1925–1926
Seah JJ, Thong M, Wang Y (2023) The diagnostic and prognostic role of biomarkers in chronic rhinosinusitis. Diagnostics (Basel) 13:715
Deng J, Wang Z, Xu Z et al (2023) Blood eosinophils to direct oral corticosteroid treatment for patients with nasal polyps - an open label, non-inferiority, randomized control trial. Rhinology. https://doi.org/10.4193/Rhin22.328
Benson VS, Fu Q, Yang S et al (2023) Real-world characterisation of patients with chronic rhinosinusitis with nasal polyps with and without surgery in England. Clin Otolaryngol. https://doi.org/10.1111/coa.14070
Bachert C, Han JK, Desrosiers MY et al (2022) Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: a randomized, placebo-controlled trial. J Allergy Clin Immunol 149:1309–1317
Acknowledgement
We are grateful to Dr. Hui-Zi Li for his technical support.
Author information
Authors and Affiliations
Contributions
G-J Huang, Z-J Fan, and S-H Li performed the conception and designed this manuscript. G-J Huang and Z-Q Chen performed data analysis and prepared the figure. G-J Huang drafted the manuscript. Z-J Fan and S-H Li revised the manuscript. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest in the work.
Ethical approval
Ethics approval or patient written informed consent were not required because the data were extracted from the public databases.
Informed consent
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Huang, GJ., Chen, ZQ., Fan, ZJ. et al. The causal association between peripheral blood eosinophils and nasal polyps: a Mendelian randomization study. Eur Arch Otorhinolaryngol 280, 4285–4290 (2023). https://doi.org/10.1007/s00405-023-08129-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-023-08129-z